ArticleCancer chemotherapy and pharmacology2024
Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression.
Deng Xiang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it